What does CUSIP 69353Y103 represent in this 13F holders report?

CUSIP 69353Y103 is the security identifier for PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in Q3 2022?

116 institutional investors reported PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK for Q3 2022. Use the holders table for investor-level position and value details.

PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP)

CUSIP: 69353Y103

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class: Equity / COMMON STOCK
Shares outstanding: 53,185,766
Total 13F shares: 58,187,852
Share change: -2,938,798
Total reported value: $692,436,457
Put/Call ratio: 66%
Price per share: $11.90
Number of holders: 116
Value change: -$36,596,424
Number of buys: 66
Number of sells: 39

Quarterly Holders Quick Answers

What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2022
Previous quarter: Q2 2022

Recent filing periods for CUSIP 69353Y103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	12%	6,563,077	$93,524,000	—	30 Jun 2022	13F
STATE STREET CORP	13F	Company	9.7%	5,171,490	$73,694,000	—	30 Jun 2022	13F
JPMORGAN CHASE & CO	13F	Company	9.2%	4,919,313	$70,100,000	—	30 Jun 2022	13F
RTW INVESTMENTS, LP	13F	Company	8.3%	4,395,677	$62,638,000	—	30 Jun 2022	13F
Boxer Capital, LLC	13F	Company	6.6%	3,498,636	$49,856,000	—	30 Jun 2022	13F
BlackRock Finance, Inc.	13F	Company	6.3%	3,358,144	$47,854,000	—	30 Jun 2022	13F
VANGUARD GROUP INC	13F	Company	6.3%	3,355,964	$47,823,000	—	30 Jun 2022	13F
Avoro Capital Advisors LLC	13F	Company	5.8%	3,100,000	$44,175,000	—	30 Jun 2022	13F
MORGAN STANLEY	13F	Company	5.8%	3,085,963	$43,975,000	—	30 Jun 2022	13F
Euclidean Capital LLC	13F 3/4/5	Company · 10%+ Owner	4.4%	2,336,909	$33,301,000	—	30 Jun 2022	13F 3/4/5
RA CAPITAL MANAGEMENT, L.P.	13F	Company	3.2%	1,710,265	$24,371,000	—	30 Jun 2022	13F
INTERWEST VENTURE MANAGEMENT CO	13F	Company	3%	1,614,911	$23,012,000	—	30 Jun 2022	13F
ALKEON CAPITAL MANAGEMENT LLC	13F	Company	2.9%	1,519,935	$21,659,000	—	30 Jun 2022	13F
CITADEL ADVISORS LLC	13F	Company	2.7%	1,410,078	$20,094,000	—	30 Jun 2022	13F
Nextech Invest Ltd.	13F	Company	2.6%	1,385,807	$19,748,000	—	30 Jun 2022	13F
PFM Health Sciences, LP	13F	Company	2.3%	1,214,164	$17,302,000	—	30 Jun 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2.1%	1,128,567	$16,083,000	—	30 Jun 2022	13F
OUP Management Co., LLC	13F	Company	1.9%	989,232	$14,097,000	—	30 Jun 2022	13F
ArrowMark Colorado Holdings LLC	13F	Company	1.6%	831,466	$11,848,000	—	30 Jun 2022	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	1.5%	821,232	$11,702,000	—	30 Jun 2022	13F
FMR LLC	13F	Company	1.5%	773,046	$11,016,000	—	30 Jun 2022	13F
INTERWEST PARTNERS X LP	3/4/5	10%+ Owner	— class O/S missing	4,502,480	$10,040,531	—	13 Jul 2021	3/4/5
Assenagon Asset Management S.A.	13F	Company	1.2%	629,539	$8,971,000	—	30 Jun 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.1%	565,533	$8,058,000	—	30 Jun 2022	13F
PERSONAL CFO SOLUTIONS, LLC	13F	Company	1%	550,342	$7,842,000	—	30 Jun 2022	13F
CITIGROUP INC	13F	Company	0.98%	521,055	$7,425,000	—	30 Jun 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.9%	476,934	$6,796,000	—	30 Jun 2022	13F
Woodline Partners LP	13F	Company	0.88%	469,883	$6,696,000	—	30 Jun 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.81%	431,926	$6,156,000	—	30 Jun 2022	13F
UBS Group AG	13F	Company	0.66%	350,310	$4,992,000	—	30 Jun 2022	13F
NORTHERN TRUST CORP	13F	Company	0.59%	313,137	$4,462,000	—	30 Jun 2022	13F
Casdin Capital, LLC	13F	Company	0.56%	300,000	$4,275,000	—	30 Jun 2022	13F
FEDERATED HERMES, INC.	13F	Company	0.47%	250,094	$3,564,000	—	30 Jun 2022	13F
Rafferty Asset Management, LLC	13F	Company	0.45%	239,864	$3,418,000	—	30 Jun 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.4%	212,897	$3,034,000	—	30 Jun 2022	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.35%	187,800	$2,676,000	—	30 Jun 2022	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.34%	183,441	$2,614,034	—	30 Jun 2022	13F
Thilo Schroeder	3/4/5	Director	— class O/S missing	1,101,283	$2,455,861	—	06 Oct 2021	3/4/5
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.29%	152,500	$2,173,000	—	30 Jun 2022	13F
BANK OF MONTREAL /CAN/	13F	Company	0.3%	158,368	$2,171,000	—	30 Jun 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.26%	137,199	$1,954,000	—	30 Jun 2022	13F
EVOKE WEALTH, LLC	13F	Company	0.25%	133,122	$1,897,000	—	30 Jun 2022	13F
BARCLAYS PLC	13F	Company	0.23%	122,751	$1,748,000	—	30 Jun 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.22%	116,999	$1,668,000	—	30 Jun 2022	13F
CANADA PENSION PLAN INVESTMENT BOARD	13F	Company	0.21%	113,500	$1,617,000	—	30 Jun 2022	13F
Bank of New York Mellon Corp	13F	Company	0.2%	104,677	$1,492,000	—	30 Jun 2022	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.15%	81,851	$1,167,000	—	30 Jun 2022	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.14%	76,602	$1,092,000	—	30 Jun 2022	13F
SG Americas Securities, LLC	13F	Company	0.12%	64,830	$924,000	—	30 Jun 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.1%	52,821	$753,000	—	30 Jun 2022	13F

Institutional Holders of PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) as of Q3 2022

As of 30 Sep 2022, PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) was held by 116 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 58,187,852 shares. The largest 10 holders included ORBIMED ADVISORS LLC, JPMORGAN CHASE & CO, RTW INVESTMENTS, LP, STATE STREET CORP, VANGUARD GROUP INC, BlackRock Inc., BOXER CAPITAL, LLC, Avoro Capital Advisors LLC, Euclidean Capital LLC, and RA CAPITAL MANAGEMENT, L.P.. This page lists 116 institutional shareholders reporting positions in this security for the Q3 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

105

Q3 2022 holders

116

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 Value $	Q3 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.